Join
Live feed
·
INSIDERFilingvia Quantisnow
Ligand Pharmaceuticals Incorporated logo

Chief Executive Officer Davis Todd C acquired $21,221 worth of shares (233 units at $91.08), increasing direct ownership by 0.14% to 161,467 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LGND· Ligand Pharmaceuticals Incorporated
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LGND (Ligand Pharmaceuticals Incorporated) and more on Quantisnow.

Chief Executive Officer Davis Todd C acquired $21,221 worth of shares (233 units at $91.08), increasing direct ownership by 0.14% to 161,467 units (SEC Form 4) | Quantisnow